Partnerships

First Approved Oral Antiviral Pill for COVID-19 Disease

This talking points document, available in Spanish and English, was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide detailed information on the first approved oral antiviral pill for COVID-19 disease.

COVID-19 Omicron (B.1.1.529) Variant

This talking points document was developed by the iREACH Subject Matter Experts to provide information on the COVID-19 Omicron variant.

SLV Toolkit

Check out AIM’s School Located Vaccination Toolkit (SLV), which is full of valuable resources for local and state immunization programs to share with schools and school districts, and K-12 school nurses and staff.
Load More
Back To Top
Search